EMBED

Enhanced Measurement-Based care Effectiveness for Depression (EMBED): A Canada-China implementation project

People gaze across the water at the Shanghai skyline.

Mood Disorder Centre researchers have been awarded a 5-year CIHR grant to improve depression treatment outcomes in Shanghai using novel tech tools.

 

We are excited to announce the Canadian Institutes of Health Research (CIHR) and National Natural Science Foundation of China (NSFC) through the Global Alliance for Chronic Diseases (GACD) have awarded a team of Mood Disorders Centre and other researchers approximately $2.1 million over 5 years to conduct a research and implementation program to improve depression treatment and outcomes in China.

The project, called “Enhanced Measurement-Based care Effectiveness for Depression” (EMBED), will adapt and develop technologies such as mobile apps, online training programs, electronic medical records, and internet, telephone and WeChat interventions to promote measurement-based care (MBC) for depression in community mental health centres across Shanghai. MBC is an evidence-based practice that can improve depression diagnosis and treatment, and technology-enabled MBC (called “enhanced” or eMBC) tools developed through the program may serve as models for future development and scale up in the region.

Principal Investigators are Dr. Raymond Lam, Professor of Psychiatry at the University of British Columbia (UBC) and Director of the Mood Disorders Centre (Canada) and Dr. Chen Jun, Professor of Psychiatry at the Shanghai Jiao Tong University (China) and Director of the Clinical Research Center at the Shanghai Mental Health Centre.

Dr. Erin Michalak, Professor in the Department of Psychiatry at UBC and a research psychologist of the Mood Disorders Centre, is also a Co-Investigator on the project.

The program is also one of the first initiatives affiliated with the Asia-Pacific Economic Cooperation’s (APEC) Digital Hub for Mental Health, which supports APEC’s vision to strengthen mental health and reduce the economic impact of mental illness in the Asia-Pacific region.

Read the press release.

Read the news article.

 

 

Grant details:

Grant Title: Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): A Canada-China Implementation Project

Funding Amount: 2.1 million over 5 years

Funding Agencies: Canadian Institutes of Health Research (CIHR) Roadmap Accelerator Fund (RAF) in partnership with the National Natural Science Foundation of China (NSFC)

Investigators:

Principal Investigator, Canada:

Dr. Raymond W. LAM, MD, FRCPC
Professor and BC Leadership Chair in Depression Research;
Associate Head for Research, Department of Psychiatry, University of British Columbia;
Director, Mood Disorders Centre, Djavad Mowafaghian Centre for Brain Health;

Principal Investigator, China:

Dr. Jun CHEN, MD, PhD
Director & Chief Physician, Depressive Disorders Program, Division of Mood Disorders
Director, Office of Clinical Research Center
Director, Office of Shanghai Clinical Center for Mental Disorders
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine (SMHC)

Co-Investigators:

Dr. Heather COLQUHOUN University of Toronto
Dr. Larry CULPEPPER Boston University
Dr. Carolyn DEWA University of California, Davis
Dr. Andrew GREENSHAW University of Alberta
Dr. Yanling HE Shanghai CDC for Mental Health
Dr. Sidney KENNEDY University of Toronto
Dr. Xin-Min LI University of Alberta
Dr. TianLi LIU Peking University
Dr. Erin MICHALAK University of British Columbia
Dr. Chee NG University of Melbourne, Australia
Dr. Sagar PARIKH University of Michigan, Ann Arbor
Dr. Claudio SOARES Queen’s University
Mr. Phil UPSHALL Mood Disorders Society of Canada
Dr. Zuowei WANG Shanghai Mental Health Center/Hongkou District Mental Health Center of Shanghai, Shanghai JiaoTong University School of Medicine
Dr. Yifeng XU Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine (SMHC)

Abstract:

Depression affects 300+ million people globally and is now the leading cause of disability and burden of disease worldwide. In China, the National Mental Health Work Plan 2015-20 specifies improving the ability of healthcare facilities to identify depression and increase the treatment rate by 50%. Measurement-based care (MBC) – the routine use of validated outcomes such as the PHQ-9 depression questionnaire to guide clinical decision-making – is a simple evidence-based practice (EBP) that may help meet these objectives. However, there is still a significant care gap in the implementation of MBC in China and elsewhere. In Canada, we have adopted the concept of enhanced MBC (eMBC), in which technology can engage both patients & physicians in using MBC; eMBC enhancements include internet and mobile app tools for patients to track their own progress with the PHQ-9, and an evidence-based, low-cost, low-intensity psychological treatment (computer/internet guided self-management with telephone/WeChat lay coaches) that has embedded patient measurement and feedback to physicians.

EMBED: a Canada-China implementation project, proposes to develop a novel EBP implementation strategy by adapting, implementing and evaluating eMBC in diverse community mental health clinics in Shanghai, modeled on programs implemented in Canada. EMBED addresses 4 broad aims: 1) identify contextual enablers & barriers to MBC implementation; 2) explore physician- and patient-level factors as mediators for an EBP implementation; 3) provide clinical & health economic outcomes to establish effectiveness of eMBC; and 4) build knowledge & capacity for scale up of eMBC in China and beyond. Our hypothesis is that physician & patient factors that are barriers for implementation of standard MBC will be enablers for implementation of eMBC.

To achieve these aims, we will first conduct a Situational Analysis to determine the key barriers & enablers for MBC implementation in Shanghai. We will adapt a Canadian eMBC program for the Chinese context, then will use a hybrid implementation-effectiveness design (an adaptive cluster randomized evaluation) to compare eMBC with standard MBC implementation in 12 community clinics, 240 physicians, and 1200 patients. We hypothesize that eMBC implementation will lead to superior implementation, patient and cost-effectiveness outcomes, compared to standard MBC.

EMBED will advance the international literature on MBC broadly by focusing on the understudied role of patients in implementation of MBC. EMBED will also further implementation science by creating new knowledge on contextual factors, including mediating effects of physician- and patient-level factors, together, on EBP implementation outcomes. Moreover, the unique partnership of the EMBED team with the APEC Digital Hub for Mental Health will ensure a pathway for integrated knowledge & policy translation so that findings will have significant scale-up and spread potential in other regions in China, the Asia-Pacific and worldwide.